ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Sep 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
Fusion Science and Technology
Latest News
Westinghouse, Nordion, and PSEG team up to produce Co‑60 in the United States
This past January, Westinghouse Electric Company, Nordion, and PSEG Nuclear formalized agreements to implement newly developed cobalt-60 production technology at Units 1 and 2 of PSEG’s Salem nuclear power plant in New Jersey, with the Co-60 to be supplied to Nordion. Through an ongoing joint initiative, the companies aim to harness U.S. pressurized water reactors to produce a key medical isotope and build the first commercial-scale Co-60 production platform in the United States.
R. G. Alsmiller, Jr., D. C. Irving, H. S. Moran
Nuclear Science and Engineering | Volume 32 | Number 1 | April 1968 | Pages 56-61
Technical Paper | doi.org/10.13182/NSE68-A18824
Articles are hosted by Taylor and Francis Online.
The straightahead approximation, i.e., the approximation that the secondary particles from nucleon-nucleus collisions are emitted in the direction of the incident nucleon, is often used in space-vehicle shielding studies. The validity of this approximation has been tested by comparing calculations made with the angular distribution of secondary particles properly taken into account with calculations using the approximation. Comparisons between the calculations are given for both monoenergetic protons and a typical flare spectrum normally incident on slab shields followed by tissue. The results indicate that the approximation is sufficiently accurate to justify its use in obtaining estimates of the secondary-particle contribution to the dose behind thin shields.